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The U.S. is currently facing an opioid crisis. Naltrexone is a common treatment for drug addiction; it reduces the 
desire to take opiates. However, addicts often stop treatment or continue to use opioids while in treatment. This results 
in increased fatalities and associated costs. A Markov-chain model is presented to analyze the progression of opioid 
addiction to assist the medical community in developing appropriate treatments. The model includes patients who 
continue opiate use while on naltrexone (blocked patients) and those who use opiates after missing naltrexone doses 
(unblocked patients). The other types of patients are abstinent (the best-case scenario) and dropout (the worst-case 
scenario). The Markov-chain model is built on probability estimates of transitions from one stage to another; the model 
predicts the proportion of patients in the different stages for a given rate of intervention on dropouts. Many factors, 
including psychological, environmental, sociodemographic, and access-to-healthcare, impact transition probabilities 
and thereby the observational data used for constructing the Markov-chain model. Markov chains have been used 
successfully in predicting the progression of HIV (Human Immunodeficiency Virus) and other diseases. Modeling 








The U.S. is currently facing an opioid crisis in which significant sections of society are getting addicted to chemicals 
that affect the brain, making opioid abuse a growing public health problem [1]. More than 702,000 persons have died 
from drug overdoses in the last 18 years since 2017 for which data are available with the Centers for Disease Control 
and Prevention. This number appears to be increasing every year. In 2017 alone, the number of casualties has exceeded 
70,000; this makes opioid abuse one of the leading causes of injury-related casualties in the country [2]. There are two 
types of addictions that come under the purview of opioid abuse: (a) abuse of prescription medications, 
methamphetamine, (meth for short), tranquilizers, and stimulants (collectively called opioids) and (b) substance 
(opiate) abuse. Two widely used prescription medications that often get abused are hydrocodone and oxycodone [1]. 
Typically, by substance abuse, one means addiction and overdose of alcohol or drugs such as heroin, cocaine, and/or 
marijuana. These three drugs (heroin, cocaine, and marijuana) are natural products and are technically called opiates, 
while opioids are essentially synthetic products that behave like opiates but are not fully natural and contain one or 
more synthetically produced ingredients. Collectively, addiction to opiates and opioids is generally called opioid 
abuse, and in this paper, the term “opioid” will mean opiates and/or opioids.  Opioid abuse is quite prevalent in the 
young adult age group [3]. This work seeks to build upon the research based on sociodemographic risk factors that 
Gosavi, A., Murray, S.L., and Karagiannis, N. 
increase susceptibility to such addictions and further use a statistical model rooted in Markov chains for (a) better 
understanding the different stages of opioid addiction and (b) potentially determining the rates of intervention needed 
to reduce the severity of this disease. In general, addiction arises from psychological factors, demographic factors, 
environmental factors, income levels, and lack of access to healthcare and treatments. In particular, a large number of 
risk factors have been studied in the young adult population [4], which will be elaborated upon later. Many patients 
remain under the radar because of poverty, homelessness, and unwillingness to disclose drug abuse and/or sexuality 
due to the unfortunate social stigma attached to such disclosures. 
 
Statistical models such as Markov chains have been widely used successfully in predicting the progression of different 
stages of HIV (Human Immunodeficiency Virus) [5] and other diseases and to analyze the different treatment 
procedures available.  The goal with such models is to reduce the spread of the disease. This is crucial in diseases for 
which a cure has not been discovered or if the patient can quickly worsen and progress to a stage where interventions 
are not possible. A major merit to developing such statistical models that capture the behavior of patients within a 
mathematical (and typically computerized) model is that one can study the effects of clinical intervention strategies 
offline. Randomized controlled trials (RCTs) that have a long history in the medical community [6] can often provide 
the initial data for statistical models. An advantage of statistical models, such as Markov-chain and discrete-event 
simulation, is that they provide a high-fidelity mechanism to test different intervention strategies – after a short RCT 
is conducted. A short RCT, for instance, would be 4-6 months long, while a prolonged RCT would have a duration of 
4-6 years. The results of prolonged RCTs can be quite negative for some of the patients involved, especially for those 
who did not receive the appropriate treatment, but which treatment was inappropriate became clear much later after 
all the results came in. Further, prolonged RCTs of this nature can take a long time-period (several months) and are 
usually expensive. In the case of opioid abuse and HIV, time is of essence, as the patient may get worse quickly 
beyond cure, or in the worst case, actually lose his/her life.  
 
The progression of opioid addiction has been studied via Markov chains in [7], where a short RCT that was 26 weeks 
(approximately 6 months) long was conducted. Patients who have dropped out, called dropouts, typically remain in 
that stage, as it is naturally difficult to track such patients. Dropping out of treatments for opioid addiction is clearly 
the least desirable outcome, as it leads to fatalities in a high proportion of cases. The overarching goal of social 
programs is to minimize the probability of this outcome and maximize that of abstinence, i.e., the stage in which the 
patient has stopped abusing opioids. The dataset in [7] provides a window to the world of opioid abuse. Very 
importantly, this dataset can be analyzed further, via the model presented here, to study and determine the appropriate 
rate of intervention on the dropouts (RID) in order to obtain a desired social outcome. RID will be defined herein as 
the proportion of the dropped-out patients who are brought back, via active interventions, to the blocked stage, where 
the patient returns to taking medications consistently but is still abusing opioids occasionally. Such interventions 
include active social interaction with the vulnerable population, as well as hard-copy advertisements (e.g., flyers) for 
getting tested and free counselling in locations frequented by vulnerable populations, along with follow-up of patients 
through other mechanisms, such as searches in existing databases. For instance, if the patient is homeless, it is likely 
that he/she has a history of different shelters visited in the past. In case the patient is a student still enrolled in college, 
there are numerous ways to try and reach out to the individual. Clearly, this kind of an intervention requires time, 
effort, and money. However, the model presented here shows how critically important interventions of this nature are 
if one desires to bring this problem under control in the long run. HIV treatments that have sought to reduce the spread 
of the virus have made active efforts to track vulnerable populations, and those efforts have produced a significant 
impact on reducing the spread of the virus [8, 9]. Similarly, RID is clearly an important strategy that can help produce 
a similar impact on reducing fatalities. In this paper, the goal is to predict the long-term outcomes, i.e., what proportion 
of patients will eventually become abstinent and what proportion will drop out, for a given rate of intervention on the 
dropout. In other words, the goal is thus to forecast the proportion of patients who will drop out of treatments and how 
many will cease using opiates for a given value of RID.  
 
2. Background and Literature Review 
A large number of factors, including sociodemographic status, homelessness, parental abuse of drugs, parental mental 
health (anxiety, depression, and anger), and prescription history, have been cited as major indicators of increased risk 
for opioid abuse within vulnerable populations [4, 10]. Young adults, it has been observed in [11]-[13], are a 
particularly vulnerable group for opioid abuse, and some of the factors named below apply specifically to them. The 
main sociodemographic and environmental factors considered in the literature are enumerated below via a numbered 
list, where the name of the factor is provided in each numbered item and the different categories for the factor 
concerned are provided within brackets:  
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(i) gender (male, female, gender-variant)  
(ii) race (White, Hispanic/Latino, African-American, Multi-Racial, Asian/Pacific Islander, Native 
American, and Other) 
(iii) sexual identity (heterosexual, homosexual, bisexual, questioning) 
(iv) housing status (homeless in the last year, never homeless, ever in foster care)  
(v) income level of parents when growing up (middle/high, low)  
(vi) prescription history of patient and parents (patient prescribed, patient never prescribed, parents 
prescribed, parents never prescribed, parents abused drugs) 
(vii) student status (attending college, completed college, college dropout, never attended college) 
 
A so-called risk profile can be constructed for any individual (typically a young adult) based on the information 
gathered via the above list.  The risk profile can be used to gauge the probability of getting addicted. The risk profile 
is directly related to how vulnerable an individual is to addiction and hence can become very useful in (a) demarcating 
patients into different risk groups that share similar characteristics and (b) in developing treatment options 
(procedures) for the different groups in the vulnerable population when diagnosed.  
 
Naltrexone is commonly used to reduce addiction to opiates. It diminishes the desire to take opiates and is also used 
to treat alcohol addiction, which is often of a less severe magnitude than addiction to the other drugs mentioned above 
(marijuana, cocaine, and heroin), and addiction to prescription medications (opioids). Prescription medications that 
can become addictive are loosely called opioids and include painkillers and central nervous system depressants, such 
as benzodiazepines (Xanax, Valium, and Ativan) used to treat anxiety and sleep disorders. The focus in this study is 
on the drugs and opioids, rather than alcohol. Patients who continue to use opiates while on naltrexone treatment 
therapy are referred to as blocked patients in the literature, while those who use opiates after having missed numerous 
naltrexone doses are called unblocked patients. There are thus two classes of patients using opioids, although they are 
under treatment. The best-case scenario is that of patients who are abstinent, while the worst-case scenario is that of 
dropout, i.e., dropping out of treatments. The patients who have dropped out are those who were formerly undergoing 
treatment but are no longer with the medical care providers. The abstinent patients are those who are responding to 
the treatment and have stopped using opiates. Overall, thus, there are four major stages in the process of treatment: 
(1) abstinent, (2) blocked, (3) unblocked, and (4) dropout. A clear demarcation of this nature helps the medical 
community understand the disease better, as well as diagnose the current state of the patient and determine which steps 
can potentially be undertaken to help the patient eventually become abstinent.  
 
3. A Markov-Chain Model 
 
Key numerical outcomes from developing a Markov chain model are: the likelihood of a patient staying in a given 
state and the frequency with which the patient can transition to a different state. Markov-chain models can capture the 
behavior of a large number of biological systems, and, as stated above, have been utilized in studying the progression 
of diseases. A finite discrete-time Markov chain, which will be used in this study, is defined by a finite number of 
distinct states of the system, where the state of the system is typically the condition of the system. In this case, the 
stage of treatment (abstinent, blocked, unblocked, or dropout) will be equivalent to the state. Thus, there will be four 
distinct states in the system under consideration.  
 
3.1. Transition Probabilities 
 
The key to using a Markov chain model is developing estimates of probabilities of transition from one state to another. 
In a Markov chain, the underlying assumption in a transition from one state (𝑖) to another (𝑗) is that regardless of 
where the system has been in the past before coming to 𝑖, its probability of transition to 𝑗 is a constant that depends 
on i and not on where the system has been before coming to i [14]. Thus, if 𝑃(𝑖, 𝑗) denotes the probability of transition 
from 𝑖 to 𝑗, then the value of 𝑃(𝑖, 𝑗) depends only on 𝑖 and 𝑗. Since these transition probabilities depend on two discrete 
variables (i and j), they can be written in the form of a matrix, P, whose element in the ith row and jth column will 
equal 𝑃(𝑖, 𝑗).  
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3.2 Steady-State Probabilities 
 
An advantage of setting up the transition probabilities is that one can then compute the long-run or steady-state 
behavior of the underlying system. Then, steady-state analysis can estimate what proportion of the affected population 
can be found in each of these four states in the long run, i.e., if the system is observed for a long time. The well-known 
steady-state equations for computing these proportions, also called steady-state probabilities, are given by (see e.g., 
[14]): 
 
                                                                           𝛱𝑷 =  𝛱                                                                                              (1) 
 
                                                                           ∑ 𝛱(𝑖) = 1𝑛𝑖=1                                                                                       (2) 
 
where 𝜫(𝒊) denotes the ith element of the row vector 𝜫,  𝒏 denotes the number of states in the system, and P denotes 
the transition probability matrix. In the above, 𝜫(𝒊) will denote the steady-state probability of state i, i.e., the 
proportion of time the system can be found in state i in the long run. The equations defined by (1) and (2) can be 
solved easily as they form a linear system of equations, allowing for the computation of the values of the steady-state 
probabilities after all the elements of the matrix P are estimated. 
 
4. Numerical Results 
 
The numerical results in this work are based on the data drawn from the short RCT conducted in [7]. It is to be noted 
that typically in an RCT, there is a main trial in which a medicinal drug is used for treatment and another trial on 
different patients in which either a placebo is used or a milder form of the treatment (or the medicinal drug) is used. 
Since naltrexone is known to be very effective, the two different types of treatment in [7] differed in the nature of the 
social interactions performed to help the patient rather than on the medicinal drug. The stronger (main) trial resulted 
in statistically better outcomes, and hence results from that trial are used here. As discussed above, the RID is not 
studied in [7], and the novelty of this work is to determine the intensity of RID needed for desirable outcomes. The 
data for the Markov chain used in the analysis here are shown via Figure 1, where each transition takes approximately 
22 weeks. Note, however, that the transitions from the dropout stage (i.e., RID-related transitions) are not considered 
in [7], and this is where this model deviates from the literature. The RID (rate of intervention of dropouts) is the 
probability of returning a patient who has dropped out to the blocked state. This probability is denoted by 𝑥 in the 
model, as shown in Figure 1. Consequently, the probability of a patient remaining in the dropout state is clearly (1 −
𝑥). Death has not been accounted for separately in this model or in [7], as it is typically associated to the dropout state 
discussed above; those in the dropout state will essentially lose their life from the effects of this disease with a high 
likelihood. Also, death is an absorbing state that poses a modeling challenge in this setting.  
 
The steady-state probabilities are computed using the matrix equations (1)—(2). A computer program was written in 
MATLAB and implemented on a computer using 2.60 GHz Intel Core i7-6700HQ processor and a 64-bit Windows 
operating system. The run time of the computer program is very short (a few microseconds), which indicates that this 
model can be used easily in practice. Table 1 shows the results of two different RID strategies (named A and B for 
convenience) for illustration. In Strategy A, the RID probability (𝑥) is 0.01, i.e., 1 out of 100 dropouts are effectively 
transferred to the blocked stage. In Strategy B, the RID probability (𝑥) is 0.5, i.e., half of those who have dropped out 
return to the blocked stage. Clearly, Strategy B would require a significantly higher amount of money and effort, as 
discussed above in Section 1.   
 
Table 1 shows the dramatically different results from Strategies A and B. Strategy A is reflective of a situation in 
which very little effort is made to track the patients who have dropped out, while Strategy B is reflective of that in 
which a significant amount of effort is made in this direction. The steady-state percentage for each stage is shown in 
Table 1, which essentially equals the steady-state probability, obtained from solving Equations (1)—(2), multiplied 
by 100. It is clear from the results in Table 1 that it is imperative to make strong efforts to track the dropouts if one 
wishes to reduce the fatalities. With a low effort (Strategy A), a very high percentage of patients (82.27%) will 
eventually die, while this percentage is significantly reduced with high effort (Strategy B) to a lower percentage 
(8.49%); of course, additional efforts can bring this rate of fatalities even lower. At the same time, the results show 
that with a low effort (Strategy A), a very low percentage of patients (13.23%) will eventually become abstinent, while 
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this percentage is significantly increased with high effort (Strategy B) to a higher percentage (68.28%). Figure 2 shows 
how the steady-state percentages of patients being in the abstinent state and in the dropout state change as the RID 
value (𝑥) is varied on a continuous spectrum. The resulting data from Figure 2 can help determine the RID needed to 
achieve a desired level of abstinence. It can also be potentially used in public-policy analysis to motivate the need for 
additional funds for social programs that can help reduce the intensity of this problem in the long run without waiting 





Figure 1: A schematic for the Markov chain in which the four states (abstinent, blocked, unblocked, and dropout) are 
denoted by four different circles and the number on the connecting arc represent the probability of the associated 
transition.  
 
Table 1: Results of the numerical results with the two strategies are shown here. 
 
RID x 𝛱(𝐴𝑏𝑠𝑡𝑖𝑛𝑒𝑛𝑡) 𝛱(𝐵𝑙𝑜𝑐𝑘𝑒𝑑) 𝛱(𝑈𝑛𝑏𝑙𝑜𝑐𝑘𝑒𝑑) 𝛱(𝐷𝑟𝑜𝑝𝑢𝑡) 
Strategy A 0.01 13.23% 2.39% 2.11% 82.27% 
Strategy B 0.5 68.28% 12.33% 10.9% 8.49% 
 

































The opioid crisis is a significant public health issue facing the nation. A significant proportion of patients suffering 
from opioid abuse remain under the radar because of social stigma and other factors such as homelessness. The opioid 
crisis has been getting increasing media attention and needs public health and strategic initiatives for resolution. 
However, the existing work does not study the rates of intervention on the dropouts, which can lead to a systemic 
understanding of the effort needed to bring about a desired long-run goal of abstinence. This work sought to provide 
numerical insights on the rates of intervention on the dropouts in order to reduce the probability of deaths. Industrial 
and systems engineers have been studying stochastic processes for many years and have a unique opportunity to team 
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